Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: An ex vivo study

Pouya Jelvehgaran*, Tanja Alderliesten, Giota Georgiou, Sybren L. Meijer, Paul R. Bloemen, Liudmila L. Kodach, Hanneke W.M. van Laarhoven, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Coen R.N. Rasch, Ton G. van Leeuwen, Johannes F. de Boer, Martijn de Bruin, Marcel van Herk

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Treatment of resectable esophageal cancer includes neoadjuvant chemo-radiation therapy (nCRT) followed by esophagectomy in operable patients. High-risk surgery may have been avoided in patients with a pathological complete response (pCR). We investigated the feasibility of optical coherence tomography (OCT) to detect residual cancer and radiation-induced fibrosis in 10 esophageal cancer patients that underwent nCRT followed by esophagectomy. We compared our OCT findings with histopathology. Overall, OCT was able to differentiate between healthy tissue, fibrotic tissue, and residual cancer with a sensitivity and specificity of 79% and 67%, respectively. Hence, OCT has the potential to add to the assessment of a pCR.

Original languageEnglish
Article number#330772
Pages (from-to)4196-4216
Number of pages21
JournalBiomedical Optics Express
Volume9
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Fingerprint Dive into the research topics of 'Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: An ex vivo study'. Together they form a unique fingerprint.

  • Cite this